ARTICLE | Company News
Cytel, Baxter Healthcare Corp. deal
March 8, 1999 8:00 AM UTC
Baxter's Nextran Inc. unit (Princeton, N.J.) received an exclusive license to CYTL's Sugar Nucleotide Cycling Technology to produce carbohydrates for use in xenotransplantation, triggering a $4 millio...